The Early History of Plasma Cell Tumors in Mice, 1954-1976†

Advances in Cancer Research

Volumn 98, Issue , 2007, Pages 17-51

  Potter, Michael ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; BACTERIAL POLYSACCHARIDE; GROWTH FACTOR; MINERAL OIL; PHOSPHORYLCHOLINE; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL CELL CULTURE; ANTIBODY PRODUCTION; ANTIBODY STRUCTURE; CHEMISTRY; DIFFUSION CHAMBER; HISTORY; IMMUNIZATION; MOUSE; MOUSE STRAIN; MULTIPLE MYELOMA; NONHUMAN; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; TUMOR IMMUNOLOGY;

ANIMALS; HISTORY, 20TH CENTURY; IMMUNOCHEMISTRY; MICE; PLASMACYTOMA;

EID: 34047261802     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(06)98002-6     Document Type: Review

References (108)

1. Anderson P.N., and Potter M. Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature 222 (1969) 994-995
2. Avigan J., Milne G.W., and Highet R.J. The occurrence of pristane and phytane in man and animals. Biochim. Biophys. Acta 144 (1967) 127-131
3. Baldo B.A., Krilis S., and Fletcher T.C. Phosphorylcholine-containing allergens. Naturwissenschaften 66 (1979) 623-625
4. Bauer S.R., Holmes K.L., Morse III H.C., and Potter M. Clonal relationship of the lymphoblastic cell line P388 to the macrophage cell line P388D1 as evidenced by immunoglobulin gene rearrangements and expression of cell surface antigens. J. Immunol. 136 (1986) 4695-4699
5. Bichel J. A transplantable plasma cell leukemia in mice preliminary report. Acta Pathol. Microbiol. Immunol. Scand. 29 (1951) 465-467
6. Binder C.J., Binder C.J., Shaw P.X., Chang M.-K., Boullier A., Hartvigsen K., Hörkkö S., Miller Y.I., Woelkers D.A., Corr M., and Witztum J.L. The role of natural antibodies in atherogenesis. J. Lipid Res. 46 (2005) 1353-1363
7. Bloom W. Lymphatic tissue: Lymphoid organs. In: Downey H. (Ed). "Handbook of Hematology" (1938), Paul B. Hoeber, Inc., New York 1427-1468
8. Blumer M., Mullin M.M., and Thomas D.W. Pristane in zooplankton. Science 140 (1963) 974
9. Brown A.R., and Crandall C.A. A phosphorylcholine idiotype related to TEPC 15 in mice infected with Ascaris suum. J. Immunol. 116 (1976) 1105-1109
10. Brundish D.E., and Baddiley J. Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate. Biochem. J. 110 (1968) 573-582
11. Burnet F.M. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust. J. Sci. 20 (1957) 67-69
12. Cajal S.R. Quelques antecedents historiques ignoressur les Plasmazellen. Anat. Anz. 29 (1906) 666-673
13. Christenson W.N., and Dacie J.V. Serum proteins in acquired haemolytic anaemia (auto-antibody type). Br. J. Haematol. 3 (1957) 153-164
14. Cisar J., Kabat E.A., Liao J., and Potter M. Immunochemical studies on mouse myeloma proteins reactive with dextrans or with fructosans and on human antilevans. J. Exp. Med. 139 (1974) 159-179
15. Cohn M. Natural history of the myeloma. Cold Spring Harb. Symp. Quant. Biol. 32 (1967) 211-221
16. Cohn M. An introduction to "Le Pap.". Cell. Immunol. 66 (1982) 11-16
17. Cohn M. The wisdom of hindsight. Annu. Rev. Immunol. 12 (1994) 1-62
18. Cohn M., Notani G., and Rice S.A. Characterization of the antibody to the C-carbohydrate produced by a transplantable mouse plasmacytoma. Immunochemistry 6 (1969) 111-123
19. Cosenza H., and Kohler H. Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science 176 (1972) 1027-1029
20. Dreyer W.J., and Bennett J.C. The molecular basis of antibody formation: A paradox. Proc. Natl. Acad. Sci. USA 54 (1965) 864-869
21. Dunn T.B. Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J. Natl. Cancer Inst. 14 (1954) 1281-1433
22. Dunn T.B. Plasma-cell neoplasms beginning in the ileocecal area in strain C3H mice. J. Natl. Cancer Inst. 19 (1957) 371-391
23. Dunn T.B., and Potter M. A transplantable mast-cell neoplasm in the mouse. J. Natl. Cancer Inst. 18 (1957) 587-601
24. Dunn T.B., Potter M., Fahey J.L., and Merwin R.M. Morphology and serum protein changes in plasma cell neoplasms in mice. Arch. De Vecchi Anat. Pathol. 31 (1960) 67-77
25. Edelman G.M., and Gally J.A. The nature of Bence-Jones proteins. J. Exp. Med. 116 (1962) 207-227
26. Edelman G.M., and Poulik M.D. Studies on structural units of the gamma-globulins. J. Exp. Med. 113 (1961) 861-884
27. Eisen H.N. The immune response to a simple antigenic determinant. Harvey Lect. 60 (1964) 1-34
28. Eisen H.N., Little J.R., Osterland C.K., and Simms E.S. A myeloma protein with antibody activity. Cold Spring Harbor Symp. Quant. Biol. 32 (1967) 75-82
29. Eisen H.N., Simms E.S., and Potter M. Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315. Biochemistry 7 (1968) 4126-4134
30. Engelbreth-Holm J. "Spontaneous and Experimental Leukaemia in Animals." (1942), Oliver and Boyd, Edinburgh
31. Fagraeus A. "Antibody Production in Relation to the Development of Plasma Cells." (1948), State Bacteriol. Lab., Stockholm
32. Fahey J.L., and Potter M. Bence Jones proteinuria associated with a transplantable mouse plasma-cell neoplasm. Nature 184 (1959) 654-655
33. Fahey J.L., Potter M., Gutter F.J., and Dunn T.B. Distinctive myeloma globulins associated with a new plasma cell neoplasm of strain C3H mice. Blood 15 (1960) 103-113
34. Fleischman J.B., Pain R.H., and Porter R.R. Reduction of gamma-globulins. Arch. Biochem. Biophys. (Suppl.) 1 (1962) 174-180
35. Freund J., Casals J., and Hosmer E.P. Sensitization and antibody formation after injection of tubercle baccilli and paraffin oil. Proc. Soc. Exp. Biol. Med. 37 (1937) 509-513
36. Grey H.M., Hirst J.W., and Cohn M. A new mouse immunoglobulin: IgG3. J. Exp. Med. 133 (1971) 289-304
37. Hilschmann N., and Craig L.C. Amino acid sequence studies with Bence-Jones proteins. Proc. Natl. Acad. Sci. USA 53 (1965) 1403-1409
38. Horibata K., and Harris A.W. Mouse myelomas and lymphomas in culture. Exp. Cell Res. 60 (1970) 61-77
39. Jerne N.K. The natural selection theory of antibody formation. Proc. Natl. Acad. Sci. USA 41 (1955) 849-857
40. Jones H.B.I. On a new substance occurrng in the urine of a patient with Mollities Ossium. Philos. Trans. R. Soc. London 138 (1847) 55-62
41. Kabat E.A. Getting started 50 years ago: Experiences, perspectives, and problems of the first 21 years. Annu. Rev. Immunol. 1 (1983) 1-32
42. Kobayashi H., Potter M., and Dunn T.B. Bone lesions produced by transplanted plasma-cell tumors in BALB/c mice. J. Natl. Cancer Inst. 28 (1962) 649-677
43. Koren H.S., Handwerger B.S., and Wunderlich J.R. Identification of macrophage like characteristics in a cultured murine tumor line. J. Immunol. 114 (1975) 894-897
44. Kritzman J., Kunkel H.G., Mccarthy J., and Mellors R.C. Studies of a Waldenstrom-type macroglobulin with rheumatoid factor properties. J. Lab. Clin. Med. 57 (1961) 905-917
45. Kyle R.A. In: Wiernik P.H., Cannellos G.P., Dutiker J.P., and Kyle R.A. (Eds). "Neoplastic Diseases of the Blood". 3 edn. (1985), Churchill Livingstone, New York 411-422
46. Lederberg J. Ontogeny of the clonal selection theory of antibody formation. Reflections on Darwin and Ehrlich. Ann. NY Acad. Sci. 546 (1988) 175-187
47. Leon M.A., and Young N.M. Specificity for phosphorylcholine of six murine myeloma proteins reactive with Pneumococcus C polysaccharide and beta-lipoprotein. Biochemistry 10 (1971) 1424-1429
48. Leon M.A., Young N.M., and McIntire K.R. Immunochemical studies of the reaction between a mouse myeloma macroglobulin and dextrans. Biochemistry 9 (1970) 1023-1030
49. Lieberman R., Douglas J.O., and Mantel N. Production in mice of ascitic fluid containing antibodies induced by staphylococcus- or salmonella-adjuvant mixtures. J. Immunol. 84 (1960) 514-529
50. Lieberman R., Potter M., Mushinski E.B., Humphrey Jr. W., and Rudikoff S. Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J. Exp. Med. 139 (1974) 983-1001
51. Lochnit G., Dennis R.D., and Geyer R. Phosphorylcholine substituents in nematodes, structure occurrence and biological implications. Biol. Chem. 381 (2000) 839-847
52. Longsworth L.G., Shedlovsky T., and MacInnes D.A. Electrophoretic patterns of normal and pathological human blood serum and plasma. J. Exp. Med. 70 (1939) 399-413
53. Lundblad A., Steller R., Kabat E.A., Hirst J.W., Weigert M.G., and Cohn M. Immunochemical studies on mouse myeloma proteins with specificity for dextran or for levan. Immunochemistry 9 (1972) 535-544
54. Marschalko T.V. Ueber die sogenannten plasmazellen, ein beitrag zur kenntniss der herkunft der entzundlichen infiltrationzellen. Archiv. fur dermatologie a Syphilis 30 (1895) 241-282
55. Marshall A.H.E., and White R.G. Reactions of the reticular tissues to antigens. Br. J. Exp. Pathol. 31 (1950) 157-174
56. Masmoudi H., Mota-Santos T., Huetz F., Coutinho A., and Cazenave P.A. All T15 Id-positive antibodies (but not the majority of VHT15 + antibodies) are produced by peritoneal CD5 + B lymphocytes. Int. Immunol. 2 (1990) 515-520
57. McIntire K.R., and Potter M. Studies of thirty different Bence Jones protein-producing plasma cell neoplasms in an inbred strain of mouse. J. Natl. Cancer Inst. 33 (1964) 631-648
58. McIntire K.R., McIntire K.R., Asofsky R.M., Potter M., and Kuff E.L. Macroglobulin-producing plasma-cell tumor in mice: Identification of a new light chain. Science 150 (1965) 360-363
59. Merwin R.M., and Algire G.H. Induction of plasma cell neoplasms and fibrosarcomas in BALB/c mice carrying diffusion chambers. Proc. Soc. Exp. Biol. Med. 101 (1959) 437-439
60. Merwin R.M., and Redmon L.W. Induction of plasma cell tumors and sarcomas in mice by diffusion chambers placed in the peritoneal cavity. J. Natl. Cancer Inst. 31 (1963) 990-1007
61. Michels N.A. The plasma cell. A critical review of its morphogenesis, function and developmental capacity under normal and under abnormal conditions. Arch. Pathol. 11 (1931) 775-793
62. Mider G.B., and Morton J.J. The effect of methylcholanthrene on the latent period of lymphomatosis in dilute brown mice. Am. J. Cancer 37 (1939) 355-363
63. Miller F.W. The induced development and histogenesis of plasma cells. J. Exp. Med. 54 (1931) 333-349
64. Milstein C., and Kohler G. Cell fusion and the derivation of cell lines producing specific antibody. In: Haber E., and Kranse R.M. (Eds). "Antibodies in Human Diagnosis and Therapy" (1977), Raven Press, New York
65. Munoz J. Production in mice of large volumes of ascites fluid containing antibodies. Proc. Soc. Exp. Biol. Med. 95 (1957) 757-759
66. Namba Y., and Hanaoka M. Immunocytology of cultured IgM-forming cells of mouse. I. Requirement of phagocytic cell factor for the growth of IgM-forming tumor cells in tissue culture. J. Immunol. 109 (1972) 1193-1200
67. Namba Y., and Hanaoka M. Immunocytology of cultured IgM-forming cells of mouse. II. Purification of phagocytic cell factor and its role in antibody formation. Cell Immunol. 12 (1974) 74-84
68. Nordan R.P., and Potter M. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 233 (1986) 566-569
69. Nossal G.J.V. Turning points in cellular immunology: The skein untangled through a global invisible college. Perspect. Biol. Med. 29 (1986) S166-S177
70. Nossal G.J.V., and Lederberg J. Antibody production by single cells. Nature 181 (1958) 1419-1420
71. Oppenheimer B.S., Oppenheimer E.T., Danishefsky I., Stout A.P., and Eirich F.R. Further studies of polymers of carcinogenic agents in animals. Cancer Res. 15 (1955) 333-340
72. Pettengill O.S., Sorenson G.D., and Elliott M.L. Murine myeloma in tissue culture. I. Light and electron microscopy and autoradiography. Arch. Pathol. 82 (1966) 483-492
73. Pilgrim H.I. The relationship of chronic ulceration of the ileocecal junction to the development of reticulo-endothelial tumors in mice. Cancer Res. 25 (1965) 53-65
74. Porter R.R. Antibody structure and the antibody workshop 1958-1965. Perspect. Biol. Med. 29 3 Part2 (1986) S161-S165
75. Porter R.R. Lecture for the Nobel Prize for physiology or medicine 1972: Structural studies of immunoglobulins. 1972. Scand. J. Immunol. 34 (1991) 381-389
76. Potter M. Mouse IgA myeloma proteins that bind polysaccharide antigens of enterobacterial origin. Fed. Proc. 29 (1970) 85-91
77. Potter M. Myeloma proteins (M-components) with antibody-like activity. N. Engl. J. Med. 284 (1971) 831-838
78. Potter M., and Boyce C.R. Induction of plasma-cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature 193 (1962) 1086-1087
79. Potter M., and Fahey J.L. Studies on eight transplantable plasma cell neoplasms of mice. J. Natl. Cancer Inst. 24 (1960) 1153-1165
80. Potter M., and Leon M. Three IgA myeloma immunoglobulins from the BALB/c mouse: Precipitation with pneumococcal C polysaccharide. Science 162 (1968) 369-371
81. Potter M., and Lieberman R. Genetic studies on the immunoglobulins of mice. Cold Spring Harbor Symp. Quant. Biol. 32 (1967) 187-202
82. Potter M., and Lieberman R. Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline. J. Exp. Med. 132 (1970) 737-751
83. Potter M., and MacCardle R.C. Histology of developing plasma cell neoplasia induced by mineral oil in Balb/C Mice. J. Natl. Cancer Inst. 33 (1964) 497-515
84. Potter M., and Robertson C.L. Development of plasma-cell neoplasms in BALB/c mice after intraperitoneal injection of paraffin-oil adjuvant, heart-killed Staphylococcus mixtures. J. Natl. Cancer Inst. 25 (1960) 847-861
85. Potter M., Fahay J.L., and Pilgrim H.J. Abnormal serum protein and bone destruction in a transmissable mouse plasma cell neoplasm. Proc. Soc. Exp. Biol. Med. 94 (1957) 327-333
86. Potter M., Lieberman R., and Dray S. Isoantibodies specific for myeloma gamma-G and gamma-H immunoglobulins of BALB-c mice. J. Mol. Biol. 16 (1966) 334-346
87. Potter M., Mushinski E.B., and Glaudemans C.P. Antigen-binding IgA myeloma proteins in mice: Specificities to antigens containing-D 1 leads to 6 linked galactose side chains and a protein antigen in wheat. J. Immunol. 108 (1972) 295-300
88. Prehn R.T., Weaver J.M., and Algire G.H. The diffusion-chamber technique applied to a study of the nature of homograft resistance. J. Natl. Cancer Inst. 15 (1954) 509-517
89. Putnam F., and Stelos P. Proteins in multiple myeloma. II. Bence Jones proteins. J. Biol. Chem. 203 (1953) 347-358
90. Putnam F.W. Alpha-, beta-, gamma-globulin: Arne Tiselius and the advent of electrophoresis. Perspect. Biol. Med. 36 (1993) 323-337
91. Rask-Nielsen R., and Gormsen H. Spontaneous and induced plasma-cell neoplasia in a strain of mice. Cancer 4 (1951) 387-397
92. Robison B.J., Pretzman C.I., and Mattingly J.A. Enzyme immune assay in which a myeloma protein is used for detection of Salmonellae. Appl. Environ. Microbiol. 45 (1983) 1816-1821
93. Rohrer J.W., and Lynch R.G. Specific immunoglobulin regulation of differentiation of immunoglobulin expression in MOPC315 cells during in vivo growth in diffusion chambers. J. Immunol. 119 (1977) 2045-2053
94. Rudikoff S., Mushinski E.B., Potter M., Glaudemans C.P.J., and Jolley M.E. Six BALB-c IgA myeloma proteins that bind beta-(1-6)-D-galactan. Partial amino acid sequences and idiotypes. J. Exp. Med. 138 (1973) 1095-1105
95. Sanger F. Chemistry of insulin. Science 129 (1959) 1340-1344
96. Seligmann M., Danon F., Basch A., and Bernard J. IgG myeloma cryoglobulin with antistreptolysin activity. Nature 220 (1968) 711-712
97. Shaw P.X., Goodyear C.S., Chang M.K., Witztum J.L., and Silverman G.J. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J. Immunol. 170 (2003) 6151-6157
98. Sher A., and Tarikas H. Hapten binding studies on mouse IgA myeloma proteins with antibody activity. J. Immunol. 106 (1971) 1227-1233
99. Smith A.M., and Potter M. A BALB/c mouse IgA myeloma protein that binds salmonella flagellar protein. J. Immunol. 114 (1975) 1847-1850
100. Stone M.J., and Metzger H. The valence of a Waldenstrom macroglobulin antibody and further thoughts on the significance of paraprotein antibodies. Cold Spring Harbor Symp. Quant. Biol. 32 (1967) 83-88
101. Sundberg D. Lymphocytes and plasma cells. Ann. NY Acad. Sci. 59 (1955) 671-681
102. Talmage D.W. Allergy and immunology. Annu. Rev. Med. 8 (1957) 239-256
103. Unna P.G. Uber Plasmazellen, insbesondere beim Lupus. Monatsh. f. Prakt. Dermat. 12 (1891) 296-317
104. Wade N. Hybridomas: The making of a revolution [news]. Science 215 (1982) 1073-1075
105. Waldenstrom J., Winblad S., Haellen J., and Liungman S. The occurrence of serological "antibody" reagins or similar gammaglobulins in conditions with monoclonal hypergammaglobulinemia, such as myeloma, macroglobulinemia etc. Acta Med. Scand. 176 (1964) 619-631
106. Weigert M.G., Cesari I.M., Yonkovich S.J., and Cohn M. Variability in the lambda light chain sequences of mouse antibody. Nature 228 (1970) 1045-1047
107. White R.G., Coons A.H., and Connolly J.M. Studies on antibody production. IV. The role of a wax fraction of mycobacterium tuberculosis in adjuvant emulsions on the production of antibody to egg albumin. J. Exp. Med. 102 (1955) 83-104
108. Wright J.H. A case of multiple myeloma. Johns Hopkins Hosp. Rpts. 9 (1906) 359-366